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INTRODUCTION 
 
The mechanisms involved in ageing and longevity are 
currently  receiving  a  great  deal  of  attention,  perhaps 
reflecting  the  impending  socioeconomic  impacts  of  a 
more  „elderly‟  society.  Recent  research  has  revealed 
roles  for  the  protein  kinase  termed  „the  target  of 
rapamycin‟ (TOR) in modulating lifespan, and for two 
of  the  processes  which  TOR  regulates,  i.e.  protein 
synthesis  and  autophagy.  Studies  in  diverse  model 
organisms  have  shown  that  impairment  of  TOR 
signaling leads to increased life span.  
 
The  mammalian  target  of  rapamycin,  mTOR,  like  its 
orthologs in other eukaryotes, is a multidomain protein 
kinase  that  interacts  with  other  proteins  to  form  two 
main  types  of  complex,  mTOR  complexes  1  and  2 
(mTORC1  and  mTORC2)  (inset  Figure  1).  Signaling 
through  mTORC1  is  much  better  understood  than 
signaling through mTORC2: mTORC1 is an important 
node in cellular regulation impacting on cell growth that 
is linked to ageing [1]. Signaling through mTORC1 is 
activated by hormones, mitogens and growth factors,  
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requires amino acids, and is negatively regulated by 
stressful  conditions,  such  as  decreased  energy  (ATP) 
availability.  While  both  mTORC1  and  mTORC2 
contain mLST8 (also termed GL), mTORC1 associates 
with  raptor,  which  binds  to  proteins  that  are  direct 
substrates for mTORC1 and mTORC2 binds to rictor. 
Although TOR‟s name reflects the fact that rapamycin 
can inhibit TOR function via an association of FKBP12 
with rapamycin which binds to the FKBP12-Rapamycin 
Binding  (FRB)  domain  of  TOR,  only  (m)TORC1  is 
sensitive  to  this  drug  in  the  short-term,  and  not  all 
functions  of  this  complex  are  blocked  by  rapamycin. 
Dysregulation  of  mTORC1  signaling  contributes  to 
several  human  diseases  –  e.g.,  cancers,  cardiac 
hypertrophy  and  tuberous  sclerosis  [2-4].    Indeed 
rapamycin, or its analogs (rapalogs), are in clinical use 
or trials for a number of diseases.  
 
mTORC1  regulates  a  range  of  essential  cellular 
functions,  the  best  understood  of  these  being  protein 
synthesis  (mRNA  translation),  which  is  positively 
regulated  by  mTORC1  (Figure  1)  [5].  Conversely, 
mTORC1  signaling  impairs  autophagy  [6],  a 
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Abstract: The molecular and cellular mechanisms that regulate ageing are currently under scrutiny because ageing is linked 
to many human diseases. The nutrient sensing TOR pathway is emerging as a key regulator of ageing. TOR signaling is 
complex affecting several crucial cellular functions and two such functions, which show clear effects on ageing, are protein 
synthesis and autophagy.  In this article we discuss the relative importance of both these processes in ageing, identify how 
TOR regulates translation and autophagy and speculate on links between the TOR signaling network and ageing pathways. 
 
 
 
 
www.impactaging.com      AGING, July   2009, Vol. 1. No 7
 
 
 
 
www.impactaging.com                  586                                              AGING, July 2009, Vol.1 No.7 degradative process through  which proteins and other 
macromolecules are broken down. This article focuses 
on the fact that both protein synthesis and autophagy are 
implicated  in  regulating  lifespan  and  ageing  and 
investigates  how  mTORC1  links  into  the  ageing 
signaling network. 
 
1) Protein synthesis 
 
Two widely-conserved effectors of mTORC1 which are 
linked to the translational machinery and its control are 
eukaryotic initiation factor (eIF) 4E and the kinases that 
phosphorylate  S6,  a  component  of  the  small  (40S) 
ribosomal  subunit  (termed  S6Ks).  The  physiological 
function of the phosphorylation of S6 [7] and the other 
S6K  substrates  functionally  associated  with  mRNA 
translation requires clarification. However, the function 
of eIF4E is far better understood.  eIF4E binds the  cap  
structure found at the 5‟-end of cytoplasmic mRNAs and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
also  interacts  with  other  proteins,    in  particular  the 
multidomain scaffold protein eIF4G [8]. eIF4G, in turn, 
interacts with several other proteins. One of these is the 
poly(A)-binding  protein  (PABP).  The  interaction  of 
eIF4G  with eIF4E  and  PABP  circularizes  the  mRNA 
(by  bringing  together  its  5‟-  and  3‟-ends),  which 
markedly enhances its translation. eIF4G also, indirect-
ly,  recruits  40S  subunits  to  the  mRNA  to  initiate 
translation at the 5‟-end. eIF4E and its interaction with 
eIF4G are therefore considered to be very important for 
the  initiation  of  mRNA  translation.  The  eIF4E:eIF4G 
interaction is blocked by the interaction of eIF4E with 
small phosphoproteins termed eIF4E-binding proteins, 
4E-BPs.  The  best  understood  of  these  is  mammalian 
4E-BP1, which is directly phosphorylated by mTORC1: 
this leads to its release from eIF4E, allowing eIF4G and 
its partners to bind [8]. In this way, mTORC1 signaling 
positively regulates eIF4E activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Signaling pathways linking mTORC1 and mTORC2 to ageing via protein 
synthesis and autophagy.  It should be noted that many links have been made in C. elegans 
and D. melanogaster and the reader is referred to Table 1 for homologs of the mammalian 
proteins in this figure.  Inset: components of mTORC1 and mTORC2. 
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Table 1. List of autophagy and protein synthesis homologs referred to in this review in S. cerivisiae, 
mammals, C.  elegans and D. melanogaster and their effects on lifespan when known 
Mammalian  S. 
cerivisiae 
C. 
elegans 
D. 
melanogaster 
Function  Effect on longevity 
Unc-51 like 
kinases 1 & 2 
(ULK1&2) 
Atg1  Unc-51  DrATG1  Induction of 
autophagy  
Loss of function 
mutation increases tissue 
ageing & decreases 
lifespan in C. elegans 
[49] 
APG5  Atg5  Atgr-5  DrATG5  Autophagosome 
assembly 
 
Beclin-1  Atg6  Bec-1  DrATG6  Autophagosome 
assembly 
Loss of function 
mutation increases tissue 
ageing & decreases 
longevity in C. elegans 
[49] 
APG7  Atg7  Atgr-7  DrATG7  Autophagosome 
assembly 
Knockdown/mutation 
reduces lifespan in D. 
melanogaster and C. 
elegans [49, 50] 
LC3 (APG8)  Atg8  Igg-1  DrATG8  Autophagosome 
assembly 
Reduced expression 
decreases longevity & 
enhanced expression 
increases lifespan in D. 
melanogaster [54,55] 
APG12  Atg12  Igg-3  DrATG12  Autophagosome 
assembly 
 
WIPI1  Atg18  Atgr-18  CG11975  Recruitment of 
protein to vesicle 
membrane 
Loss of function 
mutation increases tissue 
ageing and decreases 
lifespan in C. elegans 
[49] 
mTOR  TOR  Let-363  DrTOR  Repression of 
autophagy 
Inhibition extends 
lifespan in yeast, C. 
elegans and D. 
melanogaster [20-22] 
S6K  Sch9p  Rsks-1  dS6K  Phosphorylates 
S6, a component 
of the 40S 
ribosomal subunit 
Impairing expression in 
C. elegans & D. 
melanogaster extends 
lifespan [37, 39] 
eIF4E  CDC33  Ife-1 – 
Ife-5 
eIF4E-4  Translation 
initiation (binds 
mRNA‟s 5‟-cap) 
Knockout in C. elegans 
extends lifespan 
independent of Daf-2 & 
TOR pathways [39] 
Mnk1 and 
Mnk2 
-  Mnk-1  Lk6  eIF4E kinase  Affects lifespan in D. 
melanogaster [43] 
FoxA 1, 2 & 3  PHA-4  Pha-4  forkhead  Transcription 
factor 
Enhanced activity 
increases lifespan [71] 
FOXO 1, 3 
and 4 
-  Daf-16  dFOXO  Transcription 
factor 
Overexpresssion 
increases lifespan in D. 
melanogaster and C. 
elegans  
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essential.  For  example,  the  accumulation  of 
mistranslated  and  potentially  misfolded  proteins  can 
lead  to  neurodegeneration  [9].  Furthermore,  protein 
synthesis  is  also  a  costly  process,  consuming  both 
amino  acids  and  energy.  Indeed,  the  proportion  of 
cellular energy used in protein synthesis is estimated to 
be as high as 30-40% of total ATP (and GTP) [10, 11]. 
This consideration is important not only with respect to 
the overall cellular energy „economy‟ but also because 
the  production  of  ATP  in  mitochondria  is  associated 
with the generation of reactive oxygen species (ROS) 
which  may  have  damaging  effects  on  cellular 
components. Interestingly, mTORC1 signaling plays a 
role  in  regulating  mitochondrial  function  [12-14].  A 
number of studies in a broad range of organisms have 
now  demonstrated  links  between  mTOR,  protein 
synthesis  and  ageing/life  span.  The  overall  thrust  of 
these  studies  is  that  inhibiting  protein  synthesis  or 
(m)TOR signaling can extend life span.  
 
2) Autophagy 
 
Autophagy is a second key process that is regulated by 
mTORC1 (Figure 1). Autophagy is a process by which 
cargo,  such  as  long-lived  proteins  and  cytoplasmic 
organelles,  is  sequestered  and  delivered  to  the 
lysosomes. Based on the cellular mechanisms of cargo 
delivery  to  lysosomes,  three  different  types  of 
autophagy  have  been  described  in  mammalian  cells 
[15]. Chaperone-mediated autophagy (CMA) is a form 
of  autophagy  wherein  a  soluble  pool  of  cytosolic 
proteins  is  targeted  to  lysosomes  for  selective 
degradation  [16].  Cytosolic  proteins  with  a  CMA-
targeting  motif  bind  to  a  receptor  protein,  the 
lysosomal-associated  membrane  protein  (LAMP-2A), 
are translocated across the membrane and are degraded 
within the hydrolase-rich lumen. In addition to CMA, 
there  are  two  other  types  of  autophagy,  macro-and 
microautophagy,  which  involve  mainly  non-selective 
engulfment  of  cytosolic  regions,  including  organelles 
and  soluble  proteins.  Macroautophagy  is  the  most 
extensively  characterized  process  where  de  novo-
formed  limiting  membranes  sequester  regions  of  the 
cytosol  (“bulk  degradation”),  but  also  selectively 
sequestrate  cellular  organelles  and  protein  aggregates 
into autophagosomes. Such double-membrane vesicles 
(autophagosomes)  then  acquire  proteases  that  are 
responsible for degrading engulfed material via a fusion 
event  with  endosomes  and  lysosomes.  The  formation 
and  fusion  of  the  autophagic  compartment  with 
lysosomes  is  regulated  by  a  protein-to-protein  and  a 
protein-to-lipid  conjugation  controlled  by  the  beclin-
VPS34  (vacuolar  protein  sorting)  and  the  mTORC1 
intracellular kinase complex. 
Although  the  process  of  autophagy  is  still  poorly 
characterized  (at  least  in  mammalian  cells),  much 
progress  has  been  made  since  yeast  genetic  studies 
identified  the  first  autophagy-related  genes  (ATGs) 
about 10 years ago. Now, more than 30 such genes have 
been  discovered.  Most  of  these  are  conserved 
throughout eukaryotes. It is well established that normal 
cellular  function  relies  on  surveillance  mechanisms, 
molecular chaperones and proteolytic systems and that 
many of these functions decline with age. It is evident 
that  the  build-up  of  damaged  cellular  components  in 
ageing cells and tissues is, at least partly, attributable to 
a decline in autophagy, including CMA [17, 18].  This 
has  been  proposed  to  be  due  to  a  decrease  in  the 
clearance of vacuoles, for example the accumulation of 
lipofuscin  with  age  in  the  lysosome  could  diminish 
lysosomal function or the lysosome could be damaged 
by  toxic  protein  products  [19].  A  decrease  in  the 
sensitivity  of  autophagy  to  regulation  by  insulin  and 
glucagon  has  also  been  suggested  to  play  a  role  in 
modulation of autophagy with age [20, 21]. 
 
There  is  extensive  evidence  that  macroautophagy 
(referred to as autophagy from here on) is negatively 
regulated by mTORC1 (eg [22] and references therein). 
However, the mechanisms by which mTORC1 controls 
autophagy  are  not  well  established.  The  mechanisms 
regulating  the  initial  stages  of  autophagy,  at  least, 
appear to involve mTOR-dependent phosphorylation of 
ULK1  (UNK-51-like  kinase),  a  mammalian 
serine/threonine  protein  kinase  (Atg1  in  yeast)  which 
forms a 3-MDa complex with Atg13 and FIP200 [23-
26]. It has also been suggested that mTOR acts on ATG 
genes through the regulation of the phosphatase PP2A 
[27]. Less direct ways by which mTOR may regulate 
autophagy are via S6K and its transcriptional targets or 
signaling through Akt (Figure 1).  For example, using 
RNAi knockdown in cell lines, S6K has recently been 
shown  to  be  required  for  the  starvation-induced 
autophagic response [28]. 
 
In  this  review  we  concentrate  on  TOR  dependent 
regulation  of  autophagy,  but  it  should  be  noted  that 
autophagy  is  also  regulated  in  a  TOR  independent 
manner, either via IP3 [29] or via other protein kinases. 
For  example,  cAMP-dependent  protein  kinase  (PKA) 
was  shown  to  inhibit  the  induction  of  autophagy  in 
yeast [30] and Atg1, 13 and 18, which are required for 
autophagy, are PKA substrates [31]. Furthermore, the 
AMP-activated  protein  kinase  (AMPK),  an  important 
energy sensor, regulates the phosphorylation of the cell-
cycle regulator, p27.  p27 can maintain autophagy in a 
human cell line [32] and its regulation is proposed to be 
an  important  determinant  of  whether  a  cell  enters  a 
survival pathway (via autophagy) or apoptosis. All these 
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have been linked with longevity. For a recent in-depth 
review  on  the  molecular  mechanisms  by  which 
autophagy  genes  interact  with  longevity  pathways  in 
diverse  organisms  the  reader  is  also  referred  to  the 
paper by Vellai [33]. 
 
3) TOR-dependent regulation of ageing via protein 
synthesis and autophagy 
 
Recently, it has been proposed that the main driver of 
ageing  is  TOR  signaling  rather  than  ROS  [34]. 
Inhibition  of  the  TOR  pathway  extends  lifespan  in 
yeast,  worms  and  flies  [35-37]  and  a  recent,  notable 
study  showed  that  rapamycin,  an  inhibitor  of  mTOR, 
fed  late  in  life  extends  lifespan  in  genetically 
heterogeneous mice [38]. Below, we discuss the ways in 
which protein synthesis and autophagy may contribute 
to the regulation of lifespan by TOR. We summarize 
drug studies in cells and animals as well as evidence 
obtained  by  genetic  analyses  in  various  model 
organisms.  For  information  on  gene  homologues  and 
their effects on longevity across model organisms the 
reader is referred to Table 1. 
 
3.1) mTOR, translation, and life-span 
In the nematode worm C. elegans, several studies have 
shown that decreasing the amount of proteins involved 
in  mRNA  translation  (ribosomal  proteins,  initiation 
factors)  extends  life  span  –  examples  of  the  latter 
include eIF4E and eIF4G as well as eIF2 and eIF2B. 
Both eIF4E and eIF4G can be controlled by mTORC1 
[39, 40]. Reduced expression of TOR or S6 kinase also 
led  to  longer  life.  It  has  been  argued  that  decreased 
protein  synthesis  rates  might  extend  lifespan  by 
reducing  energy  consumption  and  thus  diminishing 
respiration  and  ROS  production.  However,  reducing 
translation  still  increased  lifespan  in  animals  with 
decreased respiration, suggesting that protein synthesis 
affects  life  span  independently  of  effects  on  energy 
usage or oxygen consumption. Other data indicate that 
the  effects  of  decreased  mTORC1  signaling  may  be 
mediated  through  reduced  mitochondrial  oxidative 
metabolism  (e.g.  [41]  and  discussion  therein).  There 
appears  to  be  a  complex  interplay  between 
mitochondria  and  (m)TOR,  with  signaling proceeding 
in  both  directions  between  them  [13].  mTORC1 
signaling promotes the transcription of genes involved 
in  mitochondrial  function  [12]  likely  as  part  of  a 
programme of events to generate the energy required by 
anabolic  processes  such  as  protein  synthesis. 
Interestingly,  the  effect  of  yeast  TORC1  on  mito-
chondrial function to influence chronological life span 
(CLS, the period in which yeast cells remain viable in a 
non-dividing  state)  occurs  not  via  mitochondrial  bio-
genesis,  but  primarily  through  translational  regulation 
of OXPHOS complexes [14]. 
  
The role of eIF4E in longevity has been the subject of 
several  recent  studies.  C.  elegans  possesses  several 
isoforms of eIF4E, with different patterns of expression 
and  differing  specificities  for  the  different  5‟-cap 
structures found in this organism. The product of the 
ife-2 gene is widely expressed in somatic tissues and 
binds  to  both  the  7-monomethyl  and  2,2,7-trimethyl 
guanosine  cap  structures  found  in  mRNAs  in  this 
species.  Knockout  of  this  gene  has  been  shown  to 
extend lifespan, in a manner distinct from the DAF-16 
(FOXO)  pathway  (Figure  1)  [39,  42],  and  enhances 
resistance to oxidative stress, UV irradiation and heat 
shock, as well as to starvation. It should be noted that in 
the study of Hansen and colleagues [39] an ife-2 mutant 
did not extend lifespan in a daf-16 mutant background, 
implying that the extension of lifespan due to loss of ife-
2  may  be  DAF-16  dependent.  Interestingly,  both 
increasing  and  decreasing  the  levels  of  the  eIF4E 
kinase, Lk6, increases lifespan in Drosophila [43].  
 
It remains to be established whether manipulations that 
inhibit general protein synthesis affect longevity due to 
the  decreased  rates  of  overall  protein  synthesis  or 
perhaps  to  the  concomitant  upregulation  of  the 
translation  of  specific  mRNAs  whose  products  help 
confer  resistance  to  stress.  A  combination  of  these 
effects  may,  of  course,  be  involved.  The  effects  of 
manipulating eIF4E activity may be especially relevant 
here,  since  eIF4E  is  involved  in  cap-dependent 
translation while many mRNAs for „stress‟ proteins are 
encoded by mRNAs by mechanisms that either show a 
low  requirement  for  the  cap-dependent  translation 
machinery  or  are  translated  by  cap-independent 
mechanisms such as internal ribosome entry segments 
(IRESs)  [44].  Since  longevity  is  promoted  by 
decreasing the  levels of initiation factors required for 
general translation (eIF2 [39]  or eIF2B  [40]) or of 
ribosomal proteins [39], it seems that impairing general 
protein synthesis, rather than specifically inhibiting cap-
dependent translation, extends lifespan.  
 
The  regulation  of  eIF4E‟s  activity  by  4E-BPs  (TOR 
substrates) could provide a mechanism by which TOR 
controls longevity. However, no structural ortholog of 
the 4E-BPs has been identified in C. elegans although it 
is possible that functional orthologs do exist. However, 
knocking down  TOR extends lifespan  further in  ife-2 
deleted worms, indicating that the effects of TOR and 
ife-2  are  mediated  through  distinct  mechanisms  [42], 
further discussed in section 4.2. Thus, TOR‟s effects on 
lifespan  in  the  worm  model  appear  to  operate  by 
additional  mechanisms.  For  example,  TOR  signaling 
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needed  for  cell  growth  and  division,  across  the 
eukaryota  from  yeast  to  mammals  [45].  Since  the 
number  of  ribosomes  in  a  cell  governs  the  cellular 
capacity  for  protein  synthesis,  decreased  ribosome 
production  may  be  involved  in  extending  lifespan  in 
animals where TOR signaling is downregulated.  
 
3.2) Autophagy and the modulation of life-span 
As  mentioned  above,  inactivation  of  TORC1  via 
treating  cells  with  rapamycin  or  nitrogen  starvation 
induces autophagy [46, 47].  The extension of lifespan 
due to TOR inhibition could potentially occur solely via 
TOR‟s  effects  on  protein  synthesis  (see  above).  
However, recent studies in C. elegans suggest a direct 
role  for  autophagy  in  modulating  longevity,  as 
inactivation of autophagy genes (bec-1, unc-51, atg-18) 
specifically  prevents  inhibition  of  TOR  activity  from 
extending lifespan [48, 49]. This indicates that TOR and 
autophagy act via the same signaling pathways to affect 
lifespan.   
 
A  recent  study  using  loss  of  function  mutational 
analysis  in C. elegans  showed  a  clear acceleration in 
tissue ageing and a reduced lifespan in worms with loss 
of  function  mutations  in  the  autophagy  genes,  bec-1, 
unc-51 and atg-18 [49]. This shows the importance of 
autophagy in regulating normal lifespan. These findings 
support an earlier study using RNAi knockdown of atg-
7 which reduced lifespan of wild-type C. elegans [50]. 
Some  other  experiments  in  C.  elegans  using  RNAi 
knockdown  of  atg-7  or  bec-1,  however,  showed  no 
significant  effects  on  lifespan  [48,  50,  51].  These 
negative findings could be explained by the finding that 
residual  Atg  activity  can  still  produce  significant 
autophagic flux (e.g. in a mammalian cell system) [52, 
53].    In  Drosophila,  mutation  of  Atg7  and  reduced 
expression  of  Atg8 each  decreased  longevity  [49,  54] 
and upregulation of the autophagy gene Atg8 increased 
longevity  [55].  Also  in  yeast,  autophagy  has  been 
implicated in ageing (reviewed in [33]). For example, a 
recent study showed that the CLS in yeast is reduced by 
deletion of Atg1 or Atg7, both required for autophagy in 
yeast [56]. Therefore, loss of autophagy controlled by 
TOR accelerates ageing. This is not unexpected because 
of the importance of autophagy in maintaining a healthy 
cellular  environment  where  damaged  proteins  and 
organelles can be eliminated.  
 
4) The role of mTOR in ageing controlled by dietary 
restriction and insulin signaling 
 
4.1) Insulin signaling 
The effect of TOR on lifespan operates downstream of 
the insulin signaling pathway (Figure 1), as indicated by 
the observation that the increase in lifespan in an insulin 
signaling  mutant  cannot  be  further  extended  by 
mutations in components of the TOR pathway [21]. A 
link  between  insulin  signaling,  ageing  and  autophagy 
was  initially  described  when  studies  in  rodent  liver 
showed that an increase in insulin with age causes an 
inhibition of autophagy and that the ability of glucagon 
to upregulate autophagy is reduced with increasing age 
[57,  58].    More  recently,  FOXO  (Daf-16)  has  been 
shown to directly control the transcription of autophagy 
genes,  including  members  of  the  Atg8  family  (LC3, 
Gabarapl1)  and  regulators  of  autophagy,  Bnip3,  and 
Atg12l  [59,  60].  Upregulation  of  FOXO  also  induces 
autophagy  in  Drosophila  [61],  C.  elegans  [59]  and 
mouse  muscle  fibres  [60].  In  addition,  a  mutation  of 
FOXO  caused  a  reduction  of  starvation-induced 
autophagy in the fat body of Drosophila [61]. The C. 
elegans  study  showed  that  the  upregulation  of 
autophagy  in  skeletal  muscle  via  Daf-16  was 
independent of mTOR, as demonstrated by inhibition of 
mTOR by rapamycin or knockdown [59].  Knockdown 
of  a  component  of  mTORC2  (rictor)  did,  however, 
result in FOXO-mediated induction of autophagy. The 
authors  explain  the  apparent  discrepancy  between  the 
lack  of  effect  of  mTOR  inhibition  and  the  positive 
effect  of  mTORC2  inhibition  on  autophagy  by  a 
negative feedback of S6K on Akt/PKB activity.  It has 
indeed become apparent that Akt signaling can be both 
positively  and  negatively  regulated  by  mTOR, 
depending on the TOR complex. As described above, 
S6K is a target of mTORC1. S6K phosphorylates IRS1 
at inhibitory sites, inhibiting activation of Akt [62, 63], 
upregulating autophagy.  On the other hand, mTORC2 
has been shown to phosphorylate S473 of Akt, hence 
activating  Akt  and  downregulating  autophagy  [64].  
This is consistent with observations in the Drosophila 
fat body, whereby signaling through TOR and PI3K is 
necessary and sufficient to suppress starvation-induced 
autophagy and yet S6K promotes autophagy [65].  The 
balance  between  mTORC1  and  mTORC2  signaling 
therefore could be critical in the regulation of Akt and 
hence autophagy and ageing. 
 
Further  evidence  linking  insulin  signaling  with 
autophagy comes from a mouse with targeted deletion 
of PTEN, in the liver. PTEN is a lipid phosphatase that 
reduces PI3K activity and hence an antagonist of insulin 
signaling, whose elimination will result in activated Akt 
and thus mTORC1.  Autophagic degradation in the liver 
of  this  mouse  was  significantly  reduced  [66].  In  C. 
elegans,  downregulation  of  the  autophagy  gene  Bec1 
inhibited the longevity phenotype of the Daf-2 insulin 
receptor  mutant  [67],  indicating  that  the  extension  of 
lifespan  due  to  alterations  in  insulin  signaling  may 
occur, at least in part, via autophagy.  
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Another  well-established  mechanism  for  promoting 
longevity  is  dietary  restriction.  Dietary  restriction  in 
many organisms, including Drosophila, C. elegans and 
rodents,  is  known  to  induce  autophagy  [65,  68,  69], 
which  is  to  be  expected  given  that  TOR  signaling  is 
impaired when amino acids levels are low.  On the other 
hand,  it  has  been  demonstrated  that  the  decline  in 
autophagy  with  increasing  age  can  be  prevented  by 
caloric restriction in mice [70].  Two autophagy genes, 
bec-1 and atg-7, have been shown to be required for the 
longevity phenotype of the inherent dietary restriction 
C.  elegans  mutant  eat-2  [48,  51]  indicating  that 
autophagy is required for the lifespan extension induced 
by dietary restriction.  
 
The FoxA family of transcription factors is involved in 
multiple  physiological  processes  including  the 
regulation of longevity in response to dietary limitation 
and related manipulations [71]. Sheaffer and colleagues 
identified the AAA+ ATPase ruvb-1 as a component of 
the TOR signaling pathway and as a negative regulator 
of the FoxA homolog pha-4 in C. elegans. They showed 
that the effects on lifespan of inactivating TOR or the 
S6K  homolog  rsks-1  requires  pha-4,  whereas  the 
lifespan-promoting  effect  of  mutations  in  eIF4E/ife-2 
does not require  pha-4. This suggests that eIF4E and 
TOR  affect  longevity  via  distinct  mechanisms. 
Therefore,  nutrient  availability  may  control  longevity 
by affecting TOR signaling and repressing or enhancing 
pha-4/FoxA function. 
The activation of autophagy due to dietary restriction in 
C. elegans was also shown to require PHA-4 (FoxA) 
activity  [48].  Pha-4  is  required  for  the  induction  of 
increased numbers of autophagic vesicles under certain 
conditions  [72],  suggesting  that  changes  in  gene 
expression are required for this process (since pha-4 is a 
transcription  factor).  In  addition  to  repressing  pha-4, 
TOR and ruvb-1 regulate the nucleolar accumulation of 
components,  termed  box  C/D  snoRNPs  that  are 
involved in the maturation of rRNAs (which are made 
in  the  nucleolus).  Impairing  TOR/ruvb-1  signaling  is 
thus  expected  to  interfere  with  ribosome  production, 
likely  explaining  the  decreased  rates  of  protein 
synthesis seen in worms where TOR signaling or box 
C/D snoRNP function is perturbed [71]. It remains to be 
elucidated  which  functions  of  pha-4  are  involved  in 
regulating lifespan.  
 
Data from yeast point to a role for Sch9p, the probable 
yeast  ortholog  of  S6K  (and  which  is  downstream  of 
TORC1) in lifespan extension due to dietary restriction 
[73]. Impairing S6K/Sch9p activity (using an inactive 
„dominant  negative‟  mutant)  also  extends  lifespan  in 
Drosophila [37]. Interfering with S6K expression in C. 
elegans  also  extended  lifespan  [39].  S6K  has  been 
implicated  in  ribosome  biogenesis,  in  oxidative 
phosphorylation  [14],  in  the  regulation  of  nucleolar 
rDNA  transcription  [45]  and  in  the  control  of  the 
translation of mRNAs for ribosome proteins (although 
recent work has revealed that S6Ks are dispensable for 
the latter (reviewed in [7]). It therefore remains to be 
established how S6K orthologs affect lifespan. 
 
Studies in yeast implicate TOR-mediated regulation of 
proteins  called  sirtuins  in  the  control  of  replicative 
lifespan. Sirtuins are NAD
+-dependent deacetylases that 
stabilize  the  rDNA  locus  and,  interestingly,  are  also 
involved in the control of lifespan by caloric restriction, 
not  only  in  yeast,  but  also  in  C.  elegans  and  in 
Drosophila [74, 75]. TOR may impair sirtuin activity 
through the induction of the Pnc1p nicotinamidase via 
the  transcription  factors  Msn2p  and  Msn4p,  whose 
nuclear  localization  is  inhibited  by  TORC1  signaling 
[74].  Recently  a  role  for  Sirt1  (Sir2  in  yeast)  in 
upregulating autophagy was revealed [76].  In this study 
Sirt1  was upregulated  in mice  subjected  to  starvation 
and  was  necessary  for  the  induction  of  starvation-
induced  autophagy.    Sirt1
-/-  mouse  fibroblasts  were 
unable to stimulate basal rates of autophagy and Sirt1 
interacted with Atg5, 7 and 8.  In yeast, TOR inhibition 
has been shown to extend lifespan by increasing Sir2 
activity, the same mechanism thought to be involved in 
extending lifespan in response to caloric restriction [74].  
Recent work in Drosophila shows that dSir2 interacts 
with and deacetylates p53, which mediates, at least in 
part, the lifespan extending effects of dietary restriction 
[77].    Therefore,  sirtuins  provide  an  important  link 
between dietary restriction, TOR signaling and ageing, 
a  link  which  may  arise  due  to  the  regulation  of 
autophagy  by  sirtuins,  via  deacetylation  and  hence 
activation of FOXO [75] (see signaling diagram) and/or 
by direct deacetylation of autophagy components [76]. 
Given that sirtuins control processes that defend cells 
against oxidative stress which, in turn, can be regulated 
by  TOR  (see  below),  it  is  noteworthy  that  SIRT3 
physically  interacts  with  the  daf-16  homolog  FOXO3 
within  mitochondria  [78],  organelles  that  are  signal 
integrators of oxidative metabolism and perhaps ageing. 
 
5)  The  interplay  of  TOR,  oxidative/mitochondrial 
metabolism and ageing 
 
The relationships between TOR signaling and oxidative 
and/or  mitochondrial  metabolism  are  complex.  While 
ROS  or  peroxides  induced  by  growth  factors  or  UV 
activate  mTOR  (e.g.  [79-83]),  exogenous  hydrogen 
peroxide inhibits mTOR (>100 μM) [84]. mTOR itself 
has been shown to both increase [85] and decrease [86] 
ROS levels. However, these studies were performed on 
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and  it  remains  to  be  seen  whether  the  modulation  of 
mTOR under basal conditions in primary tissues causes 
significant changes in cellular redox-homeostasis.  
 
There  is  increasing  evidence  that  mTOR-regulated 
autophagy plays a dual role in the cellular response to 
oxidative stress. On the one hand autophagic pathways 
are  compromised  due  to  ageing  and  in  age-related 
disorders  such  as  Alzheimer‟s  and  Huntington‟s 
Disease, which could lead to accumulation of oxidized 
proteins in aged cells under normal growth conditions 
[87, 88]. This suggests that upregulation of autophagy 
protects  against  free  radical  damage.  Indeed, 
pharmacological induction of autophagy decreased the 
age-dependent  accumulation  of  oxidatively-damaged 
mitochondrial DNA in rat liver [89, 90].  This view is 
also  supported  by  genetic  studies:  for  example, 
enhanced  Atg-8  expression  in  old  Drosophila  brains 
extends adult life span, promotes resistance to oxidative 
stress and reduces the accumulation of oxidized proteins 
[55].  Additionally,  the  age-dependent  reduction  in 
autophagy may cause the build-up of severely damaged 
mitochondria,  further  increasing  oxidative  stress  and 
causing  additional  molecular,  cellular  and  tissue 
damage  with  age.  Hence  autophagy  may  provide  the 
front line of defense against oxidative stress. The recent 
finding that Atg4, an essential protease that controls the 
lipid  modification  of  Atg8  and  autophagosome 
formation, is a direct target for oxidation by hydrogen 
peroxide, further underlines this idea. It has also been 
suggested that low levels of ROS provide a signal to 
regulate  autophagic  survival  and  death  processes 
(reviewed in [91]). Collectively, the evidence suggests 
that  free  radicals  are  upstream  and  downstream  of 
mTOR and numerous feedback and feed forward loops 
exist. For a conceptual view on the role of ROS versus 
TOR  in  ageing  the  reader  is  referred  to  the  recent 
review by Blagosklonny [34].  
 
On the other hand, in addition to its role in promoting 
cell  survival  and  increasing  life  span,  autophagy  can 
actually result in cell death (autophagic or type II cell 
death)  [92]  that  is  observed  under  conditions  of 
oxidative stress. It has been demonstrated that hydrogen 
peroxide  induces  autophagy  via  a  novel  autophagy 
signaling  mechanism  that  links  PARP-1  activation  to 
the  LKB-1-AMPK-mTOR  pathway.  Hence  PARP-1 
activation  appears  to  promote  autophagy.  Poly(ADP-
ribose) polymerases are well known for repairing single 
and double DNA strand breaks and therefore they play a 
role  in  maintaining  genomic  stability,  preventing 
carcinogenesis  and  ageing  (reviewed  in  [93]).  In  this 
context it is important to note that p53, the “guardian of  
the cellular genome” that senses cellular damage, both 
positively [94] and negatively [95] regulates autophagy. 
While nuclear p53 transactivates autophagy-enhancing 
genes [94, 96], the cytoplasmic pool of p53 can act as a 
negative  regulator  of  autophagy.  Knockout  of  p53 
stimulates autophagy in human, mouse and C. elegans 
cells [95] . The tumor suppressor p53 favors organismal 
ageing  [97,  98].  p53  gain-of-function  mutations  are 
linked  to  accelerated  ageing  and  premature  death  in 
mice  [99]  and  humans  [100],  whereas  a  dominant 
negative  p53  transgene  increases  longevity  in 
Drosophila [101] and loss of function mutations of the 
C. elegans p53 ortholog cep1 extends life span [102]. 
Hence, a recent study tested whether a mutation in cep1 
increases life span in worms via an increase in baseline 
autophagy.  Tavernarakis  and  colleagues  found  that 
RNAi  against  the  autophagy  gene  bec-1  significantly 
reduced  life  span  extension  caused  by  cep-1  mutants 
[103].  It  is  likely  that  this  functional  link  between 
increased life span and increased autophagy due to the 
cep-1  mutation  are  TOR  dependent  as  in  mammalian 
cells  knockout  and  knockdown  of  p53  causes  an 
inhibition  of  mTOR  [95].  The  exact  molecular 
mechanisms  and  signaling  between  p53  and  (m)TOR 
activity and its relationship to ageing is expected to be 
rather complex and remains to be determined.  
 
CONCLUSION 
 
There  is  overwhelming  evidence  that  cellular 
mechanisms and signaling pathways regulating ageing 
are  controlled  by  mTOR.  Here  we  have  highlighted 
important  studies  that  support  a  role  for  both  mTOR 
dependent protein synthesis and  autophagy in ageing. 
Genetic  approaches  show  a  clear  overlap  between 
signaling networks that control ageing and autophagy. 
An increase in autophagy controlled by mTOR extends 
life  span  via  dietary  restriction  and  insulin  signaling. 
Causal links, if any, between mTOR dependent ageing 
and the regulation of cellular redox-homeostasis are less 
clear and are only beginning to emerge. Key factors that 
regulate longevity and enhance autophagy such as p53, 
FOXOs  and  sirtuins  are  therefore  targets  in  the  fight 
against  age-related  diseases.  Several  genetic  studies 
provide  good  evidence  that  decreasing  protein 
translation  extends  life  span  (e.g.  via  elF4E).  While 
there  are  no  established  links  between  translation, 
insulin  signaling  and  longevity,  dietary  restriction 
appears to affect longevity via S6Ks, perhaps also by 
acting on ribosome biogenesis. However, more work is 
now  needed  to  establish  the  molecular  links  for 
mTOR‟s  role  in  ageing  via  protein  synthesis.  Such 
future work will establish whether and how to harness 
the protein synthesis machinery for therapeutic purpose.  
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